Objectives: Magnetic resonance colonography (MRC) is a well-accepted, noninvasive imaging modality for the depiction of inflammatory bowel disease. Diffusion-weighted imaging (DWI) is very helpful to display inflammatory lesions. The aim of this retrospective study was to assess whether intravenous contrast is needed to depict inflammatory lesions in bowel magnetic resonance imaging if DWI is available. Materials and Methods: Thirty-seven patients (23 females, 14 males; mean age, 14.6 years) underwent MRC on a 1.5-T scanner (MAGNETOM Avanto; Siemens). Contrast-enhanced T1-weighted (ce-T1-w) sequences and DWI sequences in axial and coronal planes (b = 50, 500, 1000) were acquired. Two reviewers evaluated (1) DWI, (2) ce-T1-w MRC, as well as (3) DWI and ce-T1-w MRC concerning lesion conspicuity. The preferred b value was assessed. Colonoscopy was performed within 1 week, including biopsies serving as the reference standard. Sensitivities and specificities were calculated, and interobserver variability was assessed. Results: Mean sensitivity and specificity of the 2 readers for the depiction of inflammatory lesions were 78.4%/100% using ce-T1-w MRC, 95.2%/100% using DWI, and 93.5%/100% combining both imaging techniques compared with colonoscopy including results of the histopathological samples. In 6 patients, inflammatory lesions were only detected by DWI; in another 6 patients, DWI detected additional lesions. The J values for the 2 readers were excellent (k = 0.92Y0.96). The preferred b value with the best detectability of the lesion was b1000 in 28 of the 30 patients (93.3%) with restricted diffusion. Conclusions: Diffusion-weighted imaging of the bowel identified inflammatory lesions with high accuracy and revealed lesions that were not detectable with ce-T1-w imaging alone. A b value of 1000 showed the best lesion detectability.
T he reliable detection of inflammatory lesions is the basis for an optimal patient management in pediatric patients with inflammatory bowel disease (IBD). Cross-sectional imaging including computed tomography and magnetic resonance imaging (MRI) all play important roles in the detection of these lesions. However, several reports advise against the routine use of computed tomographic enterography for the detection of inflammatory lesions because of the risk for ionizing radiation.
1,2 Therefore, MRI of the small and large bowel (magnetic resonance [MR] enterography and colonography) should be the first-line imaging techniques in the assessment of patients with IBD because of the high diagnostic accuracy and the lack of ionizing radiation, which is especially desirable in pediatric patients. 3Y5 In addition, some studies have demonstrated that the therapeutic strategy often changed because of the results of MRI in patients with IBD. 6, 7 However, MRI of the bowel, by now, necessitates the administration of an intravenous contrast agent. Especially since the detection of nephrogenic systemic fibrosis, a rare but serious complication of gadolinium-based contrast agents, there is less willingness to use intravenous contrast agents in MRI, 8 mainly in patients with a high probability of renal insufficiency that occasionally occurs in patients with IBD. 9 Diffusion-weighted imaging (DWI) is an emerging MR technique that allows the visualization of thermally induced motion of water molecules. Initially, it has been used in cerebral MRI, 10, 11 but in recent years, DWI has also been applied to the whole body, including the abdomen. 12, 13 Several studies show the potential of DWI for tumor detection and staging. 14Y16 Furthermore, DWI has been proven useful for the evaluation of inflammation and infections. 17, 18 Initial studies using DWI in adult and pediatric patients with IBD such as Crohn's disease and ulcerative colitis revealed a high diagnostic accuracy regarding the detection of inflammatory lesions. 17,19Y21 To our knowledge, only 2 very recent studies comparing the diagnostic accuracy of DWI and conventional bowel MRI using a gadolinium-based contrast agent exist. 17, 22 However, colonoscopy as the criterion standard for the detection of inflammatory bowel lesions was only available in two thirds of the patients in the first study and not included in the second study. In addition, these studies focus on the evaluation of patients with a confirmed diagnosis of Crohn's disease, whereas studies for patients with ulcerative colitis and patients suspected as having IBD are missing.
The aims of this retrospective study were the following: (1) to assess the diagnostic accuracy of (a) DWI, (b) conventional MR colonography using a gadolinium-based contrast agent, and (c) the combined data set using colonoscopy as the reference standard and (2) to compare the results of the 3 MR data sets to assess whether a contrast agent is indeed essential for the reliable diagnosis of inflammatory lesions in children and adolescents with IBD.
MATERIALS AND METHODS

Patients
Thirty-seven consecutive patients (23 females, 14 males) with a mean (SD) age of 14.6 (3.0) years (range, 7.2Y21.0 years) were enrolled. All patients were referred from the pediatric gastroenterological outpatient clinic for an MRI of the bowel because of suspected (n = 21) or confirmed IBD (n = 16). Thirteen of the 16 patients with known IBD had Crohn's disease, and 3 patients had proven ulcerative colitis.
Bowel cleansing was perfomed in all patients starting 1 day before the examination (Golytely; Braintree Laboratories). On the day of the examination, the patients started to drink a solution containing mannitol and locust bean gum (the aim was 1500 mL, but according to ability and disease severity) 45 minutes before the MR examination. 24 A rectal enema was not performed, but the oral contrast agent had already passed the small bowel, leading to sufficient distension of the large bowel. All patients received scopolamine (Buscopan, Boehringer Ingelheim, Germany), adapted to body weight, to reduce motion artifacts and to increase bowel distention. 25 No general anesthesia or sedation was necessary for imaging.
A dose of 0.1-mmol/kg body weight gadobutrol (Gadovist; Bayer Health Care, Berlin, Germany) was injected intravenously. T1-weighted turbo spin echo sequences in axial and coronal planes were performed in the equilibrium phase (starting 3 minutes after contrast administration; repetition time, 190 milliseconds; echo time, 1.84 milliseconds; flip angle, 70 degrees; field of view, 400 mm; slice thickness, 5 mm; gap, 0.5 mm; matrix size, 230 Â 256; time of acquisition, 16 seconds). Afterward, DWI sequences in the axial and coronal planes were collected (b = 50, 500, 1000 s/mm ; echo planar imaging factor, 150) and was acquired with a parallel imaging accelerator factor of 2 (syngo generalized autocalibrating partially parallel acquisition), and 3 averages were used for DWI. Corresponding apparent diffusion coefficient (ADC) maps were calculated.
Colonoscopy
All patients underwent conventional colonoscopy within 1 week after bowel MRI. All procedures were performed by or under supervision of a pediatric gastroenterologist using standard equipment (CF-HQ190L or CF-H180DI; Olympus Medical Systems, Tokyo, Japan).
Sedatives (2Y3 mg of midazolam hydrochloride, Dormicum; Roche, Germany) and analgesics (25Y50 mg of pethidin, Dolantin; Hoechst, Germany) as well as 40-to 280-mg propofol (Disoprovan; AstraZeneca, Wedel, Germany) were routinely administered. Targeted and step biopsies were performed, which were subsequently analyzed through histopathology.
Evaluation of histopathological samples was performed according to the recent guidelines of Crohn's disease and ulcerative colitis.
26,27
Data Analysis
Two radiologists (9 and 4 years' experience in abdominal imaging) analyzed the 3 data sets separately on a dedicated postprocessing workstation (syngo; Siemens Healthcare, Erlangen, Germany). To reduce any bias, the radiologists were blinded to clinical and laboratory data of the patients and data sets were reviewed in random order with a time interval between 3 and 5 weeks between readout.
The 2 reviewers evaluated (1) DWI, (2) contrast-enhanced T1-weighted MRC (ce-T1-w MRC), as well as (3) a combined data set including DWI and ce-T1-w MRC concerning determinable lesions of the terminal ileum and colon (1, none; 2, 1/continuous lesion(s); 3, multiple, discontinuous lesions). Furthermore, bowel distension (1, good; 2, moderate; 3, poor distension), b values, in which the lesion(s) is/are visible (1 = 50, 2 = 500, 3 = 1000, 4 = 50/500, 5 = 50/1000, 6 = 500/1000, 7 = 50/500/1000), and the preferred b value (50, 500, 1000) were assessed and correlated. For DWI, all b values and the ADC maps were used: an increased signal in the DWI images, together with a signal loss in the ADC maps, was rated as positive for a lesion. Colonoscopy and biopsy probes served as the reference standards.
Statistical calculations were performed using the Statistical Package for the Social Sciences Software Package (SPSS Statistics, version 19.0; SPSS Inc, Chicago, IL). Sensitivities, specificities, as well as positive and negative predictive values (PPVs, NPVs) for the presence of lesions were calculated for all 3 data sets and compared with colonoscopy alone and with the combination of colonoscopy and the results of the biopsy probes. The assessment results of the DWI and ce-T1-w MRC data sets were compared using the W 2 test for each reader. In addition, sensitivity, specificity, and accuracy of the different data sets (reference standard: the combination of colonoscopy and the results of the histopathological samples) were compared using the Fisher exact test.
Interrater variability was evaluated using the J coefficient. A J values less than 0. 
Ethical Considerations
This retrospective study was performed in accordance with the regulations of the local ethics committee. Informed written consent was obtained from all patients before the examination.
RESULTS
Magnetic resonance images and colonoscopies of the 37 patients were performed without any adverse effects, technical failure, or withdrawal. No data set had to be excluded because of artifacts or other reasons. Oral contrast was well tolerated by the patients, and the average intake was approximately 1000 mL because of the patients' limited ability caused by illness and incompliance to drink 1500 mL. Bowel distension was rated ''good'' in 11 (29.7%), ''moderate'' in 17 (45.9%), and ''poor'' in 9 (24.3%) patients.
Colonoscopy
Inflammatory lesions were detected in 29 of the 37 patients using colonoscopy. One/continuous lesion(s) were detected in 17 of these 29 patients; multiple discontinuous lesions, in the remaining 12 patients. All these lesions were confirmed through histopathology.
In 8 of the 37 patients, colonoscopy did not detect pathological findings. However, in 2 of these 8 patients, inflammation was detected in the histopathological samples taken during the colonoscopy.
Detection of Inflammatory Lesions Using ce-T1-w MRC
In the ce-T1-w MRC data set, both readers agreed in the assessment of 35 of the 37 patients regarding inflammatory lesions (J = 0.92): they identified no lesions in 13, 1/continuous lesion(s) in 15 ( Fig. 1) , and multiple discontinuous lesions in 7 patients. Mean sensitivity was 77.6% (reader 1, 75.9%; reader 2, 79.3%) for the detection of lesions in the ce-T1-w MRC data set compared with colonoscopy, with a specificity of 87.5% for each reader. Including the results of the histopathological probes taken during the colonoscopy, sensitivity and specificity increased for both readers (mean sensitivity, 78.4% [reader 1, 76.7%; reader 2, 80.0%]; specificity, 100% for both readers; Table 1 ). The readers disagreed in 2 patients. In 1 of these 2 patients, the first reader rated for multiple, discontinuous lesions, whereas the second reader identified only 1 lesion. Diffusion-weighted imaging and colonoscopy revealed multiple lesions in this patient. In the second patient, the first reader rated for no lesion, whereas, in the other reader, DWI and colonoscopy identified 1 lesion.
Detection of Inflammatory Lesions Using DWI
In the DWI data set, both readers agreed in the assessment of 35 of the 37 patients regarding inflammatory lesions (J = 0.92): they identified no lesions in 7, 1/continuous lesion(s) in 16 ( Fig. 1) , and multiple, discontinuous lesions in 12 patients. The mean sensitivity for the detection of pathological lesions using the DWI data set was 94.9% (reader 1, 93.1%; reader 2, 96.6%); specificity was 75.0% for each reader. Including the results of the histopathological samples during the colonoscopy, sensitivity and specificity also increased for both readers (mean sensitivity, 95.2% [reader 1, 93.5%; reader 2, 96.8%]; specificity was 100% for both readers; Table 1 ). In 1 of the 2 patients with discordant assessment, reader 2 suspected additional lesion(s) in 1 patient (discontinuous lesions instead of 1/continuous lesion(s)), which was affirmed neither by reader 1 nor by colonoscopy. In the second patient, reader 2 suspected 1/continuous lesion(s), which was confirmed by colonoscopy (ce-T1-w MRC: both readers, ''no lesions''; DWI: first reader, ''no lesion''; second reader, ''1/continuous lesion(s)''; combined DWI and ce-T1-w MRC: both readers, ''no lesions''; colonoscopy: pancolitis; Fig. 2 ).
Detection of Inflammatory Lesions Using DWI Compared With ce-T1-w MRC
In 6 of the patients (2 patients with suspected IBD, 2 patients with Crohn's disease, and 2 patients with ulcerative colitis) with nonambiguous lesions identified in DWI, no inflammatory lesion was suspected in ce-T1-w MRC (Table 2) . Colonoscopy confirmed the suspected inflammatory lesions in 5 of the 6 patients (Fig. 3) . In the remaining patient, colonoscopy was unspecific. However, the histological samples collected during the colonoscopy revealed a mucosal atrophy in the suspected area in DWI. Furthermore, additional lesions were identified in DWI in 6 other patients (DWI: multiple, discontinuous lesions; ce-T1-w MRC, 1/continuous lesion(s)). All these additional lesions were confirmed through colonoscopy. The different results of the DWI data set and ce-T1-w MRC were statistically significant for each reader using the W 2 test (P G 0.001). No statistically significant differences were detected for sensitivity (P = 0.05 for reader 2, P = 0.08 for reader 1), accuracy (P = 0.06 for reader 2, P = 0.08 for reader 1), and specificity (P 9 0.99 for both readers) using the combination of colonoscopy and the results of the histopathological samples as a reference standard (the Fisher exact test; Table 1 ). In the ce-T1-w MRC data set, 72.3% (for reader 1) and 81.8% (for reader 2) of the sets with good bowel distension were rated correctly, 94.1% (both reader) in the children with moderate bowel distension and only 55.6% (both readers) in children with poor distension. In the DWI data set, 100% of the children with good bowel distension were rated correctly (both readers), 94.1% (reader 1) / 100% (reader 2) in the children with moderate bowel distension and 88.9% (both readers) in children with poor bowel distension.
Detection of Inflammatory Lesions Using the Combined Data Set
In the combined data set (DWI and ce-T1-w MRC), the readers agreed in the assessment of 36 of the 37 patients with regard to inflammatory lesions (J = 0.96). Except for 1 patient (the second patient with nonconcordant assessment described in the DWI data set), all evaluations were exactly similar to the ones for the DWI data set. Compared with colonoscopy as the criterion standard, reader 1 correctly identified 33 and reader 2 correctly identified 32 of the 37 patients in the combined MR data set (Table 3) . This results in a sensitivity of 93.1% and a specificity of 75.0% for each reader. Including the results of the histopathological probes during the colonoscopy, sensitivity and specificity also increased for both readers (sensitivity/ specificity for both readers, 93.5%/100%; Table 1 ). No statistically different results were detected between DWI, ce-T1w MRI, and the combination of the 2 in terms of sensitivity, specificity, and accuracy.
Noncorresponding Findings of MRI and Colonoscopy
Both readers independently did not suspect pathological lesions in 2 patients with pancolitis confirmed through colonoscopy 
FIGURE 2.
Images taken from a 17-year-old adolescent girl with known ulcerative colitis and inflammatory changes in the whole colon (arrows) only detected in DWI b1000 (A) and ADC (B) by 1 reader, whereas the other reader in DWI and both readers in ce-T1-w (C) and the combined data set did not suspect inflammatory changes. Colonoscopy (D) confirmed ulcerative pancolitis, and histopathology (E) revealed a diffuse increase in lymphocytes, plasma cells, and neutrophil granulocytes. Figure 2 can be viewed online in color at www.investigativeradiology.com.
( Table 3 ). However, as described previously, reader 2 found a suspicious lesion in DWI in 1 of the 2 patients (Fig. 2) . Bowel distension was poor in 1 patient and moderate in the other patient with pancolitis. Furthermore, both readers suspected 1/continuous lesion(s) in 2 patients in the ce-T1-w MRC, DWI, and combined data set with no pathological findings in the colonoscopy. However, the histological probes taken during the colonoscopy revealed abnormal mucosa in both patients (patient 1, mucosal atrophy; patient 2, lymphofollicular hyperplasia; Fig. 4) . If a combination of colonoscopy and histopathology instead of colonoscopy alone was taken into account for these 2 patients as a reference standard for lesion detection, diagnostic accuracy increased, as described, further (Table 1) .
DWI: Diagnostic Value of the Different b Values
Diffusion-restricted lesions were identified in 30 of the 37 patients. The preferred b value with the best identifiability of the lesion was b1000 in 28 patients (93.3%) and b500 in 2 patients (6.7%; Fig. 1 ). The lesions were visible in all 3 b values (b50/500/ 1000) in 11 patients (36.7%), only in b500 and b1000 but not in b50 in 18 patients (60.0%), and only in b1000 in 1 patient (3.3%).
DISCUSSION
In this study, we could prove that DWI is superior to ce-T1-w MRC and performed equally to the combination of both sequences in the detection of inflammatory bowel lesions. Prior studies assessing the detection of inflammatory lesions in adult and pediatric patients with IBD using ce-T1-w MRC yielded moderate to good results.
3,28Y30 Gee et al 3 achieved a sensitivity of 90% and a specificity of 82.6%, whereas Dillmann et al 28 described only a sensitivity of 66% and a specificity of 90% for the detection of active inflammation in pediatric patients with Crohn's disease. These results are comparable with our findings using ce-T1-w MRC alone (mean sensitivity/specificity of 77.6%/87.5% compared with colonoscopy and 78.4%/100% compared with colonoscopy including the results of histopathological samples taken during the colonoscopy).
However, in recent years, DWI has been increasingly used for the detection of inflammatory lesions in adults and children with IBD. 17,19Y21,31,32 In our study, sensitivity and specificity were excellent for the detection of inflammatory lesions using DWI (mean sensitivity/specificity of 94.9%/75.0% compared with colonoscopy and 95.2%/100% compared with colonoscopy including the results of histopathological samples taken during the colonoscopy). Our results of DWI were statistically significantly better than those of ce-T1-w MRC for both readers comparing the assessment results of DWI data set and ce-T1-w MRC for each reader (P G 0.001). Unfortunately, the patient number seems too small to show statistically significant differences between the results of DWI and ce-T1-w MRC compared with the combination of colonoscopy and the results of the histopathological samples as the reference standard regarding sensitivity (P = 0.05 for reader 2, P = 0.08 for reader 1) and accuracy (P = 0.06 for reader 2, P = 0.08 for reader 1) with a high tendency toward DWI. Therefore, future studies with higher patient numbers are necessary to confirm our findings.
However, 6 patients with inflammatory lesions confirmed through colonoscopy or histopathology were detected only by DWI and not by ce-T1-w MRC. Without the performance of colonoscopy, the inflammatory lesions in these children would not have been detected and therapy would have been either delayed or not performed at all. In another 6 patients, additional lesion(s) were detected by DWI only. Our results are superior to those of Kiryu et al, 19 who achieved a sensitivity of 85.7% and a specificity of 75.7% in the detection of inflammatory lesions in patients with Crohn's disease using free-breathing DWI. However, in this study, histopathological results after the surgery were only available in 14 patients, whereas conventional barium study served as the criterion standard in the other 17 patients.
To our knowledge, only 2 other studies comparing the results of DWI and conventional bowel MR in patients with Crohn's disease exist. 17, 22 Neubauer et al 17 showed that DWI was superior to contrastenhanced MRI in 27% of the assessed bowel segments in 33 children and young adults with Crohn's disease compared with conventional imaging. In the second study, Buisson et al 22 postulated a comparable diagnostic accuracy for DWI and conventional MRI. However, in contrast to our study, in the first work, colonoscopy was only available in two thirds of the patients and, in the second study, no colonoscopic results were included as the reference standard. In addition, both studies used only 2 different b values (0 and 800 s/mm 2 ), whereas we used 3 different b values (50, 500, 1000 s/mm 2 ) and evaluated the usefulness of those. The influence of number and parameters of b values will be discussed later.
Similar to the patient group of Neubauer et al, 17 the falsepositive rate of DWI was very low in our study. The less experienced reader suspected an additional lesion in 1 patient (discontinuous lesions instead of 1/continuous lesion(s)). However, the more experienced reader correctly quoted ''1/continuous lesion(s)'' in this patient. This false-positive finding might be caused by the lack of experience in the assessment of DWI.
It has been shown that inclusion of DWI in the bowel MRI protocol improves diagnostic confidence. 33 To our knowledge, this is the first study showing that results of DWI alone are equally good as those of the combination of DWI and ce-T1-w MRC in patients with IBD. In 1 patient, DWI alone was even superior to the combined data set. Because of these results, we suggest that the use of contrast is not essential for the detection of inflammatory lesions in patients with suspected or confirmed IBD. Using DWI instead of ce-T1-w MRC or the combined data set would decrease acquisition time and the need for an intravenous access, which is especially desirable in children. Especially in children with impaired renal function, MRI should be performed without contrast because of the increased risk for nephrogenic systemic fibrosis. 8 Despite the excellent agreement between the results of DWI/ the combined data set and colonoscopy, we had 4 patients with nonconcordant results. Two patients with pancolitis were missed by the combined data set by both readers. This may be caused by the uniform presentation of the whole colon, which was mistaken as inconspicuous or artificial. However, 1 reader noticed a suspicious finding in DWI in 1 of these 2 patients. In 2 other patients with suspected lesions in DWI by both readers and unsuspicious colonoscopy, the histopathological samples taken during the colonoscopy revealed abnormal mucosa in the suspected areas. Because of these results, we chose to estimate sensitivity and specificity not only for colonoscopy but also for the results of the combination of colonoscopy and histopathological samples taken during the colonoscopy. In addition, we suggest that the results of the histopathological samples of suspected areas taken during the colonoscopy should always be included in future studies comparing DWI and colonoscopy to exclude confounding results. We might even be able to tell the clinicians where to take the biopsy in patients with unsuspicious colonoscopy to maintain the diagnosis if MRI is performed before colonoscopy, but this possibility has to be assessed in future studies.
Another topic still under discussion is the question of how bowel distension influences overall diagnostic accuracy in ce-T1-w MRC and DWI. In our study group, there were a lot of incorrect results in the children with poor bowel distension (55.6% correct results) compared with those with moderate (94.1%) and good bowel distension (72.3% [for reader 1]/81.8% [for reader 2]) using ce-T1-w MRC. Therefore, good bowel distension seems to be very important in detecting inflammatory lesions reliably in ce-T1-w MRC. However, most of the children were not able to drink 1500 mL of the oral contrast, the average intake instead being approximately1000 mL. Using DWI, the degree of bowel distension had less impact on detection of inflammatory lesions in our study group. Some investigators postulated that DWI even without bowel preparation is a reliable tool to detect inflammatory lesions. 19, 21 This is an interesting aspect, especially for children, because bowel preparation is a time-consuming procedure and some patients, especially young children, do not tolerate it. This would be a further advantage using DWI in children with IBD.
The aim of our study was a qualitative analysis focusing on the detection, not on the differentiation, of lesions. Therefore, we did not perform ADC value measurements because the intention of this study was not to assess diffusion restriction as in the previous studies performed in IBD to quantify disease activity 20 or stage disease severity. 34 In addition, we chose to assess interrater variability between an experienced and a less experienced radiologist to assess whether or not the level of experience has an influence on lesion detection in DWI. Interrater variability was excellent for ce-T1-w MRC, DWI, and the combined data set, showing that even less experienced readers are able to detect inflammatory lesions with these sequences.
Another important controversial issue in the literature relates to the number and parameters of the b values in DWI. Although only 2 b values (including a low b value, eg, of 0 or 50 s/mm 2 and a higher b value of 500Y1000 s/mm 2) are necessary, a greater number of b values will improve the accuracy of the calculated ADC. 35 However, more b values will result in longer scan times. Prior studies applying DWI in the gut mostly used 2 b values (0/600 s/mm 2 or 0/1000 s/mm 2 ), 17,20Y22,34,36,37 whereas only a few studies used 3 (0/50/800 s/mm 2 or 0/500/1000 s/mm 2 ). 19, 31, 32 We used 3 b values to improve the accuracy of the calculated ADC values and to compare the results of the different b values. In our study, all inflammatory lesions were seen in b1000 and all but 1 in b500. In addition, b1000 was the preferred b value in most of the patients. Diffusion-weighted imaging using high b values has been shown to provide strong background suppression and was therefore used in many studies for the detection of lesions throughout the body.
14,38 Nasu et al 39 also observed that the occurrence of false-positive results decreases with the use of b1000. During our investigation, we noticed that b1000 provides better suppression of bowel content compared with b50 and b500. In b50, it was often proven impossible to differentiate between diffusion restriction and bowel content. Nevertheless, b500 was preferred in 2 patients; therefore, we will go on to perform DWI with 3 b values.
The limitations of our work should be acknowledged. Major limitations arise from the retrospective design of our study, and furthermore, we were only able to include 37 patients. However, despite the small number of patients and the retrospective design, we believe that our findings are of high value as a preliminary study. Further, prospective studies are therefore needed to confirm our results.
In conclusion, DWI of the bowel shows inflammatory lesions with high accuracy and identified lesions that were not detected with ce-T1-w imaging. Therefore, DWI might to be able to replace or, certainly, to complement ce-T1-w MRC. This technique could be used for short examinations during therapy response assessments and should be evaluated in future trials.
